References
- Kishimoto T. The biology of Interleukin-6. Blood 1989; 74: 1–10
- Paul W. Interleukin 4: A prototypic regulatory lymphokine. Blood 1991; 77: 1859–70
- Okada M., Sakaguchi N., Yoshimura N., Hara H., Shimizu K., Yoshida N., Yoshizaki K., Kishimoto S., Yamamura Y., Kishimoto T. B-cell growth factor (BCGF) and B-cell differentiation factor from human T hybridomas: Two distinct kinds of BCGFs and their synergism in B cell proliferation. Journal of Experimental Medicine 1983; 157: 583–90
- Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., Paul W. Identification of a T-cell derived B-cell growth factor distinct from Interleukin-2. Journal of Experimental Medicine 1982; 155: 914–23
- Oliver K., Noelle R. J., Uhr J. W., Krammer P. H., Vittetta E. S. B-cell growth factor (B-cell growth factor 1 or B-cell stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce growth. Proceedings of the National Academy of Science 1985; 82: 2465–67
- Muraguchi A., Kishimoto T., Miki Y., Kuritani T., Kaieda T., Yoshizaki K., Yamamura Y. T cell-replacing factor (TRF)-induced IgG secretion in human B blastoid cell line and demonstration of acceptors for TRF. Journal of Immunology 1981; 127: 412–6
- Dutton R. W., Falkoff R., Hirst J. A., Hoffman M., Kappler J., Kettman J. R., Lesley J. F., Van D. Is there evidence for a nonantigen specific diffusible chemical mediator from the thymus cell in the initiation of the immune response. Progress in Immunology 1971; 1: 355–70
- O'Garra A., Umland S., de France T., Christiansen J. “B cell factors” are pleotrophic. Immunology Today 1988; 9: 45–53
- Hirano T., Akira S., Taga T., Kishimoto T. Biological and clinical aspects of Interleukin 6. Immunology Today 1990; 11: 443–99
- Ohara J., Paul W. E. Receptors for B-cell stimulatory factor-1 expressed on cells of haemopoietic lineage. Nature 1987; 325: 537–40
- Taga T., Kawanishi Y., Hardy R. R., Hirano T., Kishimoto T. Receptors for B cell stimulating factor 2. Journal of Experimental Medicine 1987; 166: 967–81
- Navarro S., Mitjavila M. T., Katz A., Doly J., Vainchenker W. Expression of Interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines. Experimental Hematology 1991; 19: 11–7
- Warburton P., Joshua D., Ioannidis R., Brown R., Yuen E., Francis S., Gibson J. Characterisation of a B-cell germinal centre cell line. Blood 1990; 76(Suppl 1)378
- Bataille R., Jourdan M., Zhang X-G., Klein B. Serum levels of Interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. Journal of Clinical Investigation 1989; 84: 2008–11